Pediatr. praxi. 2026;27(3):186-188 | DOI: 10.36290/ped.2026.030

Case report of severe congenital neutropenia

MUDr. Pavel Mazánek
Oddělení dětské hematologie Fakultní nemocnice Brno, Lékařská fakulta Masarykovy univerzity ERN-EuroBloodNet (European Reference Network on Rare Hematological Diseases)

Severe congenital neutropenia (SCN) comprises a group of rare hematological disorders characterized by profound neutropenia (ANC < 0.5 × 10⁹/L) and impaired neutrophil maturation in the bone marrow. The disease typically presents in early infancy with recurrent and potentially life-threatening bacterial infections. The most common genetic causes include mutations in the ELANE and HAX1 genes. SCN is associated with an increased risk of progression to myelodysplastic syndrome and acute myeloid leukemia. Granulocyte colony-stimulating factor (G-CSF) is the mainstay of therapy, significantly improving neutrophil counts and reducing infections. Hematopoietic stem cell transplantation remains the only curative option.

Keywords: neutropenia, agranulocytosis, infants, toddlers, recurrent severe infections.

Accepted: June 22, 2026; Published: July 1, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mazánek P. Case report of severe congenital neutropenia. Pediatr. praxi. 2026;27(3):186-188. doi: 10.36290/ped.2026.030.
Download citation

References

  1. Skokowa J, et al. Severe congenital neutropenias. Nat. Rev. Dis. Primers. 2017;3:17032. Go to original source... Go to PubMed...
  2. Donadieu J, et al. Congenital neutropenia: diagnosis, molecular bases and patient management. Orphanet J. Rare Dis. 2011;6:26. Go to original source...
  3. Carlsson G, et al. Incidence and clinical features of severe congenital neutropenia in Sweden. J. Pediatr. 2012;160:40-44.e1.
  4. Horwitz, M, et al. Mutations in the ELA2 gene associated with severe congenital neutropenia. Nat. Genet. 1999;23:433-436. Go to original source...
  5. Germeshausen M, et al. The spectrum of ELANE mutations and their relation to severe congenital and cyclic neutropenia. Hum. Mutat. 2013;34:905-914. Go to original source...
  6. Klein C, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat. Genet. 2007;39:86-92. Go to original source...
  7. Boztug K, et al. A syndrome with congenital neutropenia and mutations in G6PC3. N. Engl. J. Med. 2009;360: 32-43. Go to original source...
  8. Boztug K, et al. JAGN1 deficiency causes aberrant myeloid cell homeostasis and congenital neutropenia. Nat. Genet. 2014;46:1021-1027. Go to original source...
  9. Germeshausen M, et al. Novel mutations in CSF3R in patients with severe congenital neutropenia. Blood. 2008;111:4934-4937. Go to original source...
  10. Skokowa J, et al. LEF-1 levels regulate hematopoietic stem cell differentiation into the granulocytic lineage. Blood. 2006;107:4373-4380.
  11. Skokowa J, et al. Mutations in the G-CSF receptor in severe congenital neutropenia. Blood. 2009;114:3049-3055.
  12. Bonilla MA, et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N. Engl. J. Med. 1989; 320:1574-1580. Go to original source...
  13. Fioredda F, et al. Stem cell transplantation in severe congenital neutropenia: an analysis from the European Group for Blood and Marrow Transplantation. Blood. 2015; 126:1885-1892. Go to original source...
  14. Zeidler C, et al. Long-term outcome of patients with severe congenital neutropenia: a retrospective analysis of the European SCN registry. Blood. 2014;123:1620-1627.
  15. Beekman R, Touw IP. G-CSF and its receptor in myeloid malignancy. Blood. 2010; 115:5131-5136. Go to original source... Go to PubMed...
  16. Nayak RC, et al. Pathogenesis and treatment of severe congenital neutropenia: recent insights and future directions. Curr. Opin. Hematol. 2015;22:1-8.




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.